Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Based on the open interest future percentage, a short build-up is seen in 62 stocks, including IRCTC, Colgate Palmolive, Dr Reddy’s Laboratories, Tata Chemicals, and Crompton Greaves Consumer Electrical

Trade setup for today: Top 15 things to know before the opening bell

CLOSING BELL: RIL (down 1.45 per cent), Tech M, Dr Reddy’s Labs, Bharti Airtel, Axis Bank, and TCS were the top laggards

Sensex, Nifty end flat after volatile day; Metal index up 2%, RIL down 1.5%

As per the enforcement report by the US health regulator, the US-based arm of Dr Reddy’s Laboratories is recalling over 48,000 cartons of a drug used to treat sneezing, runny or stuffy nose. It is recalling 25,176 cartons of 30-count tablets and 22,968 cartons of 20-count tablets.

Why Dr Reddy’s and Sun Pharma are recalling certain products from US market

New Jersey-based Dr Reddy’s Laboratories, Inc initiated the Class III recall on November 21 this year. As per USFDA, a Class III recall is initiated in a “situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences”.

Dr Reddy’s, Sun Pharma recall products in US for manufacturing issues

“The complaint, which purports to be on behalf of a class of indirect purchasers, asserts claims under federal and state antitrust laws and other state laws alleging that the defendants improperly restrained competition and maintained a shared monopoly in the sale of brand and generic Revlimid throu…

Dr Reddy’s Laboratories among other generic pharma companies in US to face antitrust litigation

Kotak Mahindra Bank, Coal India, HDFC Bank, Dr Reddy’s Laboratories and HUL were among the top Nifty gainers

Taking Stock | Sensex, Nifty end flat amid volatility; power, realty, metals top drags

Based on the open interest future percentage, there were 69 stocks in which a short-covering was seen, including Gujarat Gas, Manappuram Finance, Deepak Nitrite, Crompton Greaves Consumer Electrical, and Dr Reddy’s Laboratories

The suit is expected to impact Natco Pharma, Dr Reddy’s Labs, Cipla, and Zydus Lifesciences. All these companies had launched Revlimid during the second COVID-19 wave in September 2021

Pharma stocks slip on concerns over first anti-competitive US lawsuit against ‘Revlimid’ makers

Top Gainers and Losers of the day (November 9): ITC, Dr Reddy’s Labs, Kotak Mahindra Bank, PowerGrid, Tech Mahindra, Sun Pharma, Bajaj Finserv and more

ITC, Dr Reddy’s Labs, PowerGrid, Tech Mahindra among top gainers & losers as market ends lower

CLOSING BELL: Hero MotoCorp, HDFC Bank, Kotak Bank, ONGC, Bharti Airtel, and Dr Reddy’s Labs, meanwhile, eked out gains up to 2.6 per cent

Sensex dips 420 pts on weak global cues; Aurobindo Pharma down 12%, TaMo 5%

Elaborating on the overall strategies, Dr Reddy’s Laboratories CEO Erez Israeli said the company’s R&D is focusing on creating “as much as possible on differentiated products, on biosimilars, on products that have bigger potential.”

Dr Reddy’s Labs lines up Rs 1,500 crore capex with focus on biosimilars, injectables

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.

Dr Reddy's Laboratories Ltd

Dr Reddy's Laboratories Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Trade setup for today: Top 15 things to know before the opening bell

Sensex, Nifty end flat after volatile day; Metal index up 2%, RIL down 1.5%

Why Dr Reddy’s and Sun Pharma are recalling certain products from US market

Dr Reddy’s, Sun Pharma recall products in US for manufacturing issues

Dr Reddy’s Laboratories among other generic pharma companies in US to face antitrust litigation

Taking Stock | Sensex, Nifty end flat amid volatility; power, realty, metals top drags

Trade setup for today: Top 15 things to know before the opening bell

Pharma stocks slip on concerns over first anti-competitive US lawsuit against ‘Revlimid’ makers

ITC, Dr Reddy’s Labs, PowerGrid, Tech Mahindra among top gainers & losers as market ends lower

Sensex dips 420 pts on weak global cues; Aurobindo Pharma down 12%, TaMo 5%

Dr Reddy's Laboratories Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Trade setup for today: Top 15 things to know before the opening bell

Sensex, Nifty end flat after volatile day; Metal index up 2%, RIL down 1.5%

Why Dr Reddy’s and Sun Pharma are recalling certain products from US market

Dr Reddy’s, Sun Pharma recall products in US for manufacturing issues

Dr Reddy’s Laboratories among other generic pharma companies in US to face antitrust litigation

Taking Stock | Sensex, Nifty end flat amid volatility; power, realty, metals top drags

Trade setup for today: Top 15 things to know before the opening bell

Pharma stocks slip on concerns over first anti-competitive US lawsuit against ‘Revlimid’ makers

ITC, Dr Reddy’s Labs, PowerGrid, Tech Mahindra among top gainers & losers as market ends lower

Sensex dips 420 pts on weak global cues; Aurobindo Pharma down 12%, TaMo 5%

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock